January 7, 2019 — JC Medical announced the successful treatment of the first U.S. patient with the company’s ...
Karen Orjuela, M.D., assistant professor of neurology at the University of Colorado Stroke and Brain Aneurysm Center ...
January 7, 2019 — Endologix Inc. announced that in order to ensure optimal outcomes for patients, unrestricted sales and ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
John Carroll, M.D., FACC, FSCAI, director of interventional cardiology, and Robert Quaife, M.D., director of advanced ...
Advances in artificial intelligence (AI) have created new threats to the privacy of people's health data, a new University of California, Berkeley, a new study shows.
January 4, 2018 — Here is the top cardiology content on the Diagnostic and Interventional Cardiology (DAIC) website from ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Interview with John Messenger, M.D., FACC, FSCAI, director of the cardiac cath labs and director of the cardiovascular ...
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a study presented recently at EuroEcho-Imaging 2018, Dec. 5-8 in Milan, Italy.
Ohio University and the National Academy of Engineering announced the 2019 Fritz J. and Dolores H. Russ Prize will be given to Julio Palmaz, Leonard Pinchuk, John Simpson, Richard Schatz and Paul Yock for innovations leading to the widespread adoption of percutaneous coronary intervention (PCI), also known as angioplasty with stent or coronary angioplasty. The $500,000 biennial prize, which recognizes a bioengineering achievement that significantly improves the human condition, cites PCI for “seminal contributions to coronary angioplasty, enabling minimally invasive treatment of advanced coronary artery disease.”
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
This is a 360 degree photo during a chronic total occlusion (CTO) procedure at the University of Colorado Hospital with ...
This is a walk through inside one of the cardiac hybrid cath labs at the University of Colorado Hospital in Aurora ...
This is a quick video tour of one of the dedicated electrophysiology (EP) labs at the University of Colorado Hospital ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
This is the newest cardiac cath lab at the University of Colorado Hospital in Aurora, Colorado. Construction was ...
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals’ Prior Approval Supplement (PAS) for its large-scale, second generation Andexxa [coagulation factor Xa (recombinant), inactivated-zhzo], allowing for broad commercial launch in the United States.
Boston Scientific Corp. exercised its option to acquire the remaining shares of Millipede Inc, a privately-held company in Santa Rosa, Calif., upon its recent successful completion of a first-in-human clinical study. The acquisition will expand the Boston Scientific Structural Heart portfolio to include the Iris Transcatheter Annuloplasty Ring System, which is in development for the treatment of patients with severe mitral regurgitation (MR) who are not able to tolerate open-heart surgery.